As developers from AstraZeneca Plc to Pfizer Inc. near the finish line for their coronavirus vaccines, nations are preparing for the challenge of rolling them out, with inevitable supply shortages fueling concerns about inequitable distribution and even the emergence of illegal markets. One place where vaccine delivery is already being road-tested is China, which has allowed local developers’ shots for emergency use since mid-year.

Europe’s drugs watchdog expects first marketing application for coronavirus vaccine in days

Nov 26, 2020

The European Medicines Agency (EMA) did not name the company it expects to file the application, but Pfizer Inc and BioNTEch are the most advanced in the regulatory process among the three companies that have published late-stage trial data for their vaccines.

World agonises over new COVID curbs as infections approach 60 million

Nov 25, 2020

an approved vaccine is unlikely to be widely available for months while scientists insist on the continued need for vigilance and politicians consider curbs for Christmas amid a second wave of the pandemic.

Fintechs seen eating into market share of established insurers, EU says

Nov 25, 2020

Insurers and reinsurers such as AXA and Munich Re have been investing in so-called insurtech companies, considered a faster way for them to adapt to technology changes.

Stephen Catlin, chairman and chief executive of Convex, a newcomer to the insurance, told the event that fintech firms faced a learning curve to compete with established players.

« Older Entries

Next Entries »

Briefs